The rapid provision of test facilities and vaccines for SARS-CoV-2 can be attributed to three main factors. Firstly, the research community had already spent thirty years working on the mRNA technology that forms the methodological basis of various vaccines for the coronavirus; they were also able to fallback on other technical approaches and experiences. Secondly, there was a unique international collaboration between science, pharmaceutical companies and biotech start-ups. The various synergies that arose from this made rapid scientific advances possible. And thirdly, the regulatory authorities of various countries allowed a fast-track approval procedure. In addition to the key factors, basic research forms the cornerstone for all medical research. No medicines or therapies can be developed without exploratory university research which is conducted without any expectation of results and is also dependent on the use of animal experiments. A crucial element of medical research on substances is always the measurement of their safety and efficacy. Animal experiments are an indispensable method of testing these two factors \u2013 also in the case of vaccines and tests for SARS-CoV-2.<\/p>\n","protected":false},"excerpt":{"rendered":"
The rapid provision of test facilities and vaccines for SARS-CoV-2 can be attributed to three main factors. Firstly, the research community had already spent thirty years working on the mRNA technology that forms the methodological basis of various vaccines for the coronavirus; they were also able to fallback on other technical approaches and experiences. Secondly, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":8303,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"page-templates\/themen-under-seite.php","meta":{"footnotes":""},"acf":[],"yoast_head":"\n